General Information of the Compound
| Compound ID |
CP0401132
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,11R,15R,16R,17S,19S)-22-benzyl-6-hydroxy-12-(2-methylpropyl)-2,4,18-trioxa-12,22-diazaheptacyclo[15.4.2.15,9.01,16.011,19.015,19.015,24]tetracosa-5,7,9(24)-trien-23-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H34N2O5
|
||||||||||||||||||
| Molecular Weight |
502.611
|
||||||||||||||||||
| Canonical SMILES |
CC(C)CN1CC[C@]23[C@@H]4[C@@H]5O[C@@]22CC[C@@]4(OCOc4c(O)ccc(C[C@@H]12)c34)N(Cc1ccccc1)C5=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H34N2O5/c1-18(2)15-31-13-12-28-23-20-8-9-21(33)24(23)35-17-36-30-11-10-29(28,22(31)14-20)37-25(26(28)30)27(34)32(30)16-19-6-4-3-5-7-19/h3-9,18,22,25-26,33H,10-17H2,1-2H3/t22-,25+,26+,28+,29-,30+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UPAZZKNYLSZQFB-HJGLZJKISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor